About
Biologics
Areas of Focus
Categories
BiosimilarsBiologics & BiopharmaceuticalVaccineChina
Clinical Trials (17)
View allTotal Trials
17
As Lead Sponsor
17
As Collaborator
0
Total Enrollment
34,266
By Phase
PHASE1: 10PHASE3: 4PHASE2/PHASE3: 2PHASE2: 1
By Status
COMPLETED: 8WITHDRAWN: 6RECRUITING: 2TERMINATED: 1
Clinical Trials Pipeline17 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06666179Lead Sponsor
Safety and Immunogenicity Study of SCB-1019T in Children
PHASE1Withdrawn
Started: Oct 31, 2025 · Completed: Dec 31, 2026
NCT06984094Lead Sponsor
First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults
PHASE1Recruiting
192 participants
Started: Jun 18, 2025 · Completed: Jun 30, 2026
NCT06843317Lead Sponsor
Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults
PHASE1Recruiting
160 participants
Started: Mar 21, 2025 · Completed: Jun 3, 2026
NCT06194318Lead Sponsor
First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults
PHASE1Completed
160 participants
Started: Dec 13, 2023 · Completed: May 7, 2025
NCT06567457Lead Sponsor
Immunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in Adults
PHASE3Withdrawn
Started: Oct 31, 2023 · Completed: Oct 31, 2024
Locations (1)
Headquarters
Changxing, China
Map
Loading map...